Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
Autores: Konstantinopolsky MA, Chernyakova IV, Kolik LG
Selank (0.3 mg/kg) reduced morphine withdrawal syndrome by 39.6% in rats, attenuating convulsive reactions and ptosis while increasing locomotor activity.
Abstract
Activity of a peptide tuftsin analogue Selank was studied in outbred rats using the naloxone-precipitated morphine withdrawal model.. Single intraperitoneal injection of Selank in an anxiolytic dose of 0.3 mg/kg reduced the total index of morphine withdrawal syndrome by 39.6%, significantly (р<0.0001) attenuated convulsive reactions, ptosis, and posture disorders, and 9-fold increased.
Hallazgos Clave
Single intraperitoneal injection of Selank in an anxiolytic dose of 0.3 mg/kg reduced the total index of morphine withdrawal syndrome by 39.6%, significantly (р<0.0001) attenuated convulsive ...Diseño del Estudio
Animal studyMore Selank Peptide: Uses, Benefits & Safety Insights Research Papers
Additional peer-reviewed studies and clinical trials indexed for Selank Peptide: Uses, Benefits & Safety Insights on PepsReview:
- Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity — Protein Pept Lett, 2018 (160 citations)
- Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats — Bull Exp Biol Med, 2019 (140 citations)
- Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress — Bull Exp Biol Med, 2019 (140 citations)
- Functional Connectomic Approach to Studying Selank and Semax Effects — Dokl Biol Sci, 2020 (120 citations)
Related Nootropic / Cognitive
Other peptides in the nootropic / cognitive category with research data available on PepsReview:
About This Selank Peptide: Uses, Benefits & Safety Insights Research Paper
This study is part of PepsReview's indexed research library for Selank Peptide: Uses, Benefits & Safety Insights. We systematically index peer-reviewed publications, clinical trial results, and scientific studies related to Selank Peptide: Uses, Benefits & Safety Insights to provide researchers and clinicians with a centralized, searchable database of evidence. Each paper in our index includes metadata such as journal name, publication year, citation count, study type, and condition studied, along with key findings and study design summaries where available.
Selank Peptide: Uses, Benefits & Safety Insights is classified in our Nootropic / Cognitive category. Discover the uses, benefits, and safety of Selank Peptide, a lab-made anxiety treatment with no addiction risk. Learn more about its applications! For a complete list of research papers on Selank Peptide: Uses, Benefits & Safety Insights, visit the research index page. To compare vendor pricing and read user reviews, visit the main Selank Peptide: Uses, Benefits & Safety Insights profile page.
Understanding Selank Peptide: Uses, Benefits & Safety Insights Research
Selank Peptide: Uses, Benefits & Safety Insights has been the subject of growing scientific interest, with researchers investigating its pharmacological properties, therapeutic potential, and safety profile across multiple study designs. The research landscape for Selank Peptide: Uses, Benefits & Safety Insights includes preclinical in vitro and animal model studies that elucidate its mechanism of action, Phase I clinical trials assessing safety and pharmacokinetics in human subjects, and larger Phase II and Phase III trials evaluating efficacy in target populations. Published studies vary in design — some are randomized controlled trials with placebo groups, others are open-label dose-escalation studies, and many are retrospective analyses of real-world data from clinics and compounding pharmacies.
When interpreting Selank Peptide: Uses, Benefits & Safety Insights research, it is important to consider several factors: the study population size and demographics, the dosage range tested, the duration of follow-up, the presence of confounding variables, and whether the results have been replicated in independent cohorts. Single studies, even well-designed ones, should not be considered definitive evidence. The strongest conclusions come from meta-analyses that pool data across multiple studies and from replicated findings across different research groups. Our research index for Selank Peptide: Uses, Benefits & Safety Insights allows you to browse all available studies in one place and compare their methodologies, outcomes, and limitations side by side.
How to Evaluate Peptide Research Quality
Not all published studies carry equal weight. When reviewing Selank Peptide: Uses, Benefits & Safety Insights research, consider the following quality indicators: peer-reviewed publication in a reputable journal with an impact factor, large sample sizes (n > 100 for clinical studies), randomized and blinded study designs, clearly defined endpoints, appropriate control groups, and disclosure of funding sources and potential conflicts of interest. Studies published in top-tier journals such as the New England Journal of Medicine, The Lancet, JAMA, or Diabetes Care undergo rigorous peer review and are generally more reliable. Preclinical studies and animal models, while valuable for hypothesis generation, should not be extrapolated to human use without clinical validation.
Additionally, pay attention to the condition studied and whether it aligns with your research interest. A study examining Selank Peptide: Uses, Benefits & Safety Insights for one condition may not be applicable to a different therapeutic context. Dosage ranges, administration routes, and treatment durations can significantly affect outcomes. Always cross-reference findings with the broader literature and consult the full text of the original publication rather than relying solely on abstracts or summaries.
Related Research on Selank Peptide: Uses, Benefits & Safety Insights
PepsReview continues to index new Selank Peptide: Uses, Benefits & Safety Insights publications as they appear in the scientific literature. Our research library is updated regularly with studies from PubMed, ClinicalTrials.gov, and direct journal submissions. If you are aware of a published study that is not yet in our index, you can contact our editorial team to request its inclusion. We also welcome submissions of conference abstracts, preprint articles, and independent lab reports that meet our quality criteria.
For researchers new to Selank Peptide: Uses, Benefits & Safety Insights, we recommend starting with the most highly cited papers in our index, as these typically represent foundational studies that have shaped the field. You can also browse by study type — clinical trials, animal studies, review articles, or case reports — to find the evidence most relevant to your work.
Research Disclaimer
The studies indexed on PepsReview are provided for educational and informational purposes only. They do not constitute medical advice. Peptides discussed in these publications may be investigational, and their safety and efficacy have not been established by the FDA unless explicitly noted. Always consult a qualified healthcare professional before making decisions based on research findings. PepsReview does not endorse, recommend, or guarantee the accuracy of any individual study. Our role is to index and organize published research for the convenience of the scientific community.